⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Connecticut Office of the Attorney General: If You Bought Certain Generic Prescription Drugs in the United States
prnewswire.com
PFE
TEVA
AMRN
BIIB
REGN
GILD
LULU
VRTX
AZN
BHC
JNJ
MRK
BMY
LLY
ABBV
SNY
HRMY
CPRX
PRGO
SRPT
AMGN
EXAS
BNTX
INCY
ALGN
LRCX
MDT
ILMN
BKR
CVS
CI
UNH
CNC
HCA
THC
HQY
MASI
QRVO
SWKS
AVGO
INTC
AMD
MU
NVDA
QCOM
ADI
NXPI
ON
MCHP
SNPS
CDNS
AMAT
KLAC
WDC
SMCI
CRDO
MDLZ
KHC
PG
CL
EL
MKC
GIS
SJM
PEP
KO
SBUX
MCD
YUM
CMG
QSR
SONO
GOOG
AMZN
MSFT
AAPL
IBM
ORCL
CSCO
HPQ
T
VZ
CMCSA
NFLX
DIS
BA
CAT
GE
XOM
CVX
SIRI
TMUS
VRSN
ADBE
CRM
NOW
PANW
SNOW
DDOG
ZS
FTNT
MRVL
ISRG
DXCM
PODD
TNDM
LPCN
ACT
ASND
GWW
GRNT
Securities Lawsuit Alert: Regeneron Pharmaceuticals, Inc. (REGN) - Contact Levi & Korsinsky Before September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Issues Important Reminder to Regeneron Pharmaceuticals, Inc. Shareholders – REGN
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Securities Fraud Class Action Filed Against Regeneron Pharmaceuticals, Inc. (REGN) - Levi & Korsinsky Reminds Investors of September 14, 2026
accessnewswire.com
REGN
Pomerantz LLP Informs Shareholders of Class Action Filing Against Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN
Pomerantz LLP Issues Important Reminder to Regeneron Pharmaceuticals, Inc. Investors – REGN
accessnewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Join Class Action Before September 14, 2026 – Contact Levi & Korsinsky
accessnewswire.com
REGN